Literature DB >> 9453398

Compartmental localization of complement component transcripts in the normal human kidney.

D Song1, W Zhou, S H Sheerin, S H Sacks.   

Abstract

Local synthesis of complement components may play a crucial role in the pathogenesis of renal disease. Previous reports have shown that a number of complement components are produced by renal tissue both in vitro and in disease states. In the present study, we focused on the topographical distribution of components of the alternative and classical activation pathways in normal human kidney. As a whole, the normal renal cortex has the capacity to express the genes corresponding to most components of both complement pathways. There appears to be relatively high expression of transcripts for factor D and properdin in glomeruli, whilst factor B expression is greater within the medulla. Components C2, C3, and C4 and factor H are expressed predominantly in cortical tubule-rich fractions, and C1q is similarly expressed in all fractions. These results suggest that there may be differing emphasis on the alternative and classical pathways of complement activation in different regions within normal kidney.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453398     DOI: 10.1159/000044876

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  13 in total

1.  The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.

Authors:  Roland Schmitt; Anne-Lie Ståhl; Anders I Olin; Ann-Charlotte Kristoffersson; Johan Rebetz; Jan Novak; Gunnar Lindahl; Diana Karpman
Journal:  J Immunol       Date:  2014-05-21       Impact factor: 5.422

2.  Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.

Authors:  Azusa Hashimoto; Yusuke Suzuki; Hitoshi Suzuki; Isao Ohsawa; Rhubell Brown; Stacy Hall; Yuichi Tanaka; Jan Novak; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  Am J Pathol       Date:  2012-08-05       Impact factor: 4.307

3.  Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B.

Authors:  David J Kaczorowski; Melanie J Scott; John P Pibris; Amin Afrazi; Atsunori Nakao; Rebecca D Edmonds; Sodam Kim; Joon H Kwak; Yujian Liu; Jie Fan; Timothy R Billiar
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

Review 4.  Complement in disease: a defence system turning offensive.

Authors:  Daniel Ricklin; Edimara S Reis; John D Lambris
Journal:  Nat Rev Nephrol       Date:  2016-05-23       Impact factor: 28.314

Review 5.  Allograft rejection: effect of local synthesis of complement.

Authors:  Steven H Sacks; Wuding Zhou
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

6.  Renoprotective Mechanism of Remote Ischemic Preconditioning Based on Transcriptomic Analysis in a Porcine Renal Ischemia Reperfusion Injury Model.

Authors:  Young Eun Yoon; Kyung Hwa Choi; Sook Young Kim; Young In Cho; Kwang Suk Lee; Kwang Hyun Kim; Seung Choul Yang; Woong Kyu Han
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

7.  Human Tamm-Horsfall protein, a renal specific protein, serves as a cofactor in complement 3b degradation.

Authors:  Diana C J Rhodes
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

8.  Which pathways trigger the role of complement in ischaemia/reperfusion injury?

Authors:  Conrad A Farrar; Elham Asgari; Wilhelm J Schwaeble; Steven H Sacks
Journal:  Front Immunol       Date:  2012-11-19       Impact factor: 7.561

Review 9.  The complement cascade and renal disease.

Authors:  Katarzyna Kościelska-Kasprzak; Dorota Bartoszek; Marta Myszka; Marcelina Zabińska; Marian Klinger
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-09-13       Impact factor: 4.291

Review 10.  Overview of complement activation and regulation.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.